
Daniel Wiznia, MD, an orthopaedic surgeon with Yale School of Medicine, is practicing a surgical technique designed to render 10% of hip replacements unnecessary. Regenerative properties from a patient’s own stem cells are responsible for regrowing bone, restoring blood flow, and being able to avoid further interventional surgery.
Osteonecrosis, also known as avascular necrosis, occurs in more than 20,000 Americans each year. As the condition progresses, bone cells known as osteoblasts become unable to repair themselves and sustain the integrity of the bone, and ultimately die. The bone deterioration leads to a decrease in blood flow to the area, further weakening the entire skeletal structure of the upper leg. If unaddressed, the ball portion of the hip’s ball and socket joint will cave in on itself and collapse, requiring a total hip replacement.
The fact that patients often receive this diagnosis during their 30s and 40s presents a particular challenge. While the lifespan of hip prosthetics has dramatically increased in recent years, a patient who undergoes a total hip arthroplasty, or total hip replacement, at that age will almost certainly require a revision later in life. This redo of the same surgery at an older age comes with an entirely new set of risks and potential complications, making it that much harder to manage down the road.
The goal in patients with this condition then becomes very clear: prevent the head of the femur (thighbone) from collapsing.
Wiznia, assistant professor of orthopaedics and rehabilitation, and of mechanical engineering and materials science, draws from both of those areas of expertise to use 3D imaging technology as part of an innovative joint-preservation procedure. In recent years, he has worked closely with the Yale School of Engineering & Applied Sciences and the Integrated 3D Surgical Team at the Yale School of Medicine to tailor this treatment to each patient. Imaging has proven to be critical to the successful outcome of this surgical technique.
“One of the challenges of orthopaedic surgery in the human body is that surgeons are operating in a three-dimensional space and are often reliant on two-dimensional imagery such as X-rays,” Wiznia says. “Through computer modeling, we are able to customize those images and create models that are specific to each patient, which, in turn, enhances outcomes and overall post-operative success rates.”
Wiznia surgically harvests bone marrow from the patient’s pelvis. By using a centrifuge inside the operating room, he is able to isolate and concentrate the individual’s own stem cells. Material containing the stem cells is then injected into the area of bone that has died.
Research has shown that stem cells possess the characteristics and qualities needed for the body to regrow, repair, and regenerate damaged tissue and bone, and according to Wiznia, this treatment dramatically reduces the risk of the head of the femur from collapsing. Soon after the procedure, many patients with avascular necrosis experience rejuvenated blood supply to the area and the bone is repopulated with new cells. This can additionally alleviate the short-term need for a hip replacement.
The major challenge in this patient population is identifying, diagnosing, and performing surgical intervention in time before the collapse. “Because the vascular injury is usually a painless event,” says Wiznia, “patients are generally unaware of the specific point in time when the injury occurred, which is why cases are rarely discovered in time.”
Patients may be encouraged to know that those who have avascular necrosis of the hip generally have it present on both sides, and it can develop on the two sides at different rates. So, even if it is detected too late on one side, there is still a chance to preserve the other.
“We usually are able to catch that second asymptomatic side in those situations and conduct the core decompression with stem cell treatment before it collapses,” Wiznia says. “This novel stem cell therapy has demonstrated improved pain and function, and the stem cells decrease the risk of the femoral head from collapsing. That ultimately translates into fewer young patients requiring hip replacements along with subsequent surgeries in their later years.”
Original Article: Stem Cell Therapy Reduces Need for Nearly 10% of Hip Replacements
More from: Yale School of Medicine
The Latest on: Stem cell therapy
- Researchers discover two-pronged approach to stimulate STING antitumor activityon March 27, 2023 at 11:45 am
When the researchers treated cells with drugs that blocked methylation, STING expression and signaling increased, leading to the production of chemical messengers that enhanced antitumor immunity.
- Understanding nitrogen metabolism could revolutionize tuberculosis treatmenton March 27, 2023 at 8:44 am
"Drug resistance is a major problem affecting tuberculosis treatment. New drugs are urgently needed to tackle the growing threat of this infectious disease and finding out more about how nitrogen is ...
- Kala Pharma Reveals Safety Data From Stem Cell Therapy Trial For Corneal Defect Impacting Around 240K People In Developed Nationson March 27, 2023 at 8:25 am
Kala Pharmaceuticals Inc (NASDAQ: KALA) announced safety data from the first cohort of the CHASE Phase 2b clinical trial evaluating KPI-012, a human mesenchymal stem cell secretome (MCS-S), for ...
- HIV genomes that hide in white blood cells offer new target to eliminate infectionson March 27, 2023 at 8:01 am
in a study using blood samples from men and women with HIV on long-term suppressive therapy, a team led by Johns Hopkins Medicine scientists reports new evidence that one such stable reservoir of HIV ...
- Immusoft Acquires Exclusive, Worldwide Rights to Intellectual Property for Genome Edited Primary B Cells from the University of Minnesotaon March 27, 2023 at 5:01 am
Immusoft, a clinical-stage cell therapy company dedicated to improving the lives of patients with rare diseases, today announced that it has successfully closed a license with the Regents of the Unive ...
- Cancer Diagnosis and Treatment Could Be Affected by Circadian Rhythmon March 27, 2023 at 5:01 am
Circadian rhythm can impact cancer development, diagnosis, and treatment. New findings may lead to novel therapies against metastasis.
- MRI-guided Radiation Therapy Systems Revenue to Top US$2.89 Billion by 2033; Hospital Segment to Lead Sales; Fact.MR Reporton March 27, 2023 at 3:00 am
The market for MRI-guided radiation therapy systems is currently valued at US$ 545.1 million and is anticipated to generate US$ 2.89 billion in sales by the end of 2033.
- Stem Cell Therapy for Osteoarthritis Market Analysis 2023-2028, Newly Upgraded Reporton March 26, 2023 at 10:30 pm
The report features the size of the global "Stem Cell Therapy for Osteoarthritis Market” in 2023, along with a ...
- NK Cell Therapy and Stem Cell Therapy Market Growth by 2031on March 24, 2023 at 6:42 pm
The MarketWatch News Department was not involved in the creation of this content. Mar 24, 2023 (The Expresswire) -- The "NK Cell Therapy and Stem Cell Therapy Market" study describes how the ...
- Cell Therapy Prevents Risk Of Heart Attack or Stroke: Studyon March 24, 2023 at 10:50 am
assessed the efficacy of mesenchymal precursor cell therapy on over 500 patients with moderate to severe heart failure. To do this, they first crafted their stem cell product. The researchers ...
via Bing News
The Latest on: Stem cell therapy
[google_news title=”” keyword=”stem cell therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
Add Comment